NeurAxis, Inc. (NRXS) NASDAQ

2.18

+0.08(+3.81%)

Updated at May 08 04:00PM

Currency In USD

NeurAxis, Inc.

Address

11550 North Meridian Street

Carmel, IN 46032

United States of America

Phone

(812) 689-0791

Sector

Healthcare

Industry

Biotechnology

Employees

21

First IPO Date

August 09, 2023

Key Executives

NameTitlePayYear Born
Mr. Brian CarricoPresident, Chief Executive Officer & Director578,3761982
Dr. Thomas CarricoChief Regulatory Officer and Compliance & Privacy Officer368,9141957
Dr. Adrian MirandaSenior Vice President of Science & Technology and Chief Medical Officer382,4451970
Mr. Timothy Robert HenrichsChief Financial Officer407,1371973
Dr. Christopher Robin Brown D.D.S.Founder, Director of Innovation & Director01954

Description

NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.